| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| 1,5500% | ₹122.2 0% | 800 | ₹0.45 -75.67% | 24,8003.22% |
| - | - | 820 | ₹1.1 -46.34% | 3,1000% |
| - | - | 840 | ₹2.1 -32.25% | 20,15018.18% |
| 7750% | ₹131 0% | 850 | ₹2.55 -33.76% | 58,1255.63% |
| - | - | 860 | ₹3.5 -33.33% | 31,00053.84% |
| - | - | 870 | ₹4.65 -26.77% | 21,7007.69% |
| 1,5500% | ₹58.9 0% | 880 | ₹5.9 -25.31% | 63,550-3.52% |
| 7750% | ₹44.4 0% | 890 | ₹7.55 -22.56% | 41,85063.63% |
| 1,06,175-3.52% | ₹58.7 13.87% | 900 | ₹9.3 -25.89% | 2,20,875-6.55% |
| 24,800-13.51% | ₹48.5 3.41% | 910 | ₹11.65 -24.35% | 47,27541.86% |
| 50,375-20.73% | ₹42.85 10.15% | 920 | ₹15.05 -17.53% | 72,8506.81% |
| 1,03,85025.23% | ₹37 12.63% | 930 | ₹18.5 -19.21% | 45,7257.27% |
| 1,27,87547.32% | ₹30.55 11.09% | 940 | ₹22.05 -20.68% | 1,90,650192.85% |
| 1,83,67522.16% | ₹25.45 10.89% | 950 | ₹27 -18.05% | 58,12517.18% |
| 2,34,825-3.80% | ₹20.65 10.42% | 960 | ₹31.95 -18.39% | 1,11,6002.85% |
| 1,51,900-1.50% | ₹17.35 11.21% | 970 | ₹38 -16.57% | 65,1001.20% |
| 1,49,5750% | ₹13.55 9.27% | 980 | ₹53.9 0% | 89,9000% |
| 75,950-4.85% | ₹10.75 8.04% | 990 | ₹41.2 -1.19% | 31,7750% |
| 4,28,575-13.18% | ₹8.75 8.02% | 1,000 | ₹70.5 0% | 1,21,6750% |
| 20,925-12.90% | ₹6.9 9.52% | 1,010 | - | - |
| 61,2250% | ₹5.4 12.5% | 1,020 | ₹60 0% | 6,9750% |
| 11,625-28.57% | ₹3.9 8.33% | 1,030 | - | - |
| 1,01,5253.14% | ₹3.25 6.55% | 1,040 | - | - |
| 34,87525% | ₹2.55 -3.77% | 1,050 | - | - |
| 50,37514.03% | ₹2.35 11.9% | 1,060 | - | - |
| 44,1750% | ₹1.5 114.28% | 1,080 | - | - |
| 1,40,2750.55% | ₹1 17.64% | 1,100 | ₹135 0% | 2,3250% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
